Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Climacteric : the Journal of the International Menopause Society|August 7, 2025
Major adverse cardiovascular events risk in menopausal women treated with oral estradiol/micronized progesterone versus conjugated estrogens/medroxyprogesterone: a claims data analysis in the USAJohn C Stevenson, Rodney Baber, Risa Kagan, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 1, 2025
Factors Associated With Non-Vasomotor Menopause Symptoms Experienced by 7285 Women: A UK-Wide National SurveyRhianna Davies, Ashwin Goyal, Zachary Nash, et al.
Climacteric : the Journal of the International Menopause Society|September 12, 2025
The role of lifestyle medicine in menopausal health: a review of non-pharmacologic interventionsChika V Anekwe, Antonio Cano, Jennifer Mulligan, et al.
Menopause (New York, N.Y.)|January 31, 2023
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)James A Simon, Richard A Anderson, Elizabeth Ballantyne, et al.
The New England Journal of Medicine|November 7, 2008
Testosterone for low libido in postmenopausal women not taking estrogenSusan R Davis, Michele Moreau, Robin Kroll, et al.
The New England Journal of Medicine|June 2, 2025
Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast CancerFatima Cardoso, Susanne Parke, Donal J Brennan, et al.
Maturitas|July 31, 2026
Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial programJoAnn V Pinkerton, James A Simon, Nick Panay, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|February 6, 2020
Purified and specific cytoplasmic pollen extract: a non-hormonal alternative for the treatment of menopausal symptomsAndrea Genazzani, Nick Panay, Tommaso Simoncini, et al.
Archives of Women'S Mental Health|January 8, 2013
Clinical subtypes of core premenstrual disorders: a Delphi surveyKhaled M K Ismail, Tracy Nevatte, Shaughn O'Brien, et al.
Menopause (New York, N.Y.)|April 2, 2024
Design of OASIS 1 and 2: phase 3 clinical trials assessing the efficacy and safety of elinzanetant for the treatment of vasomotor symptoms associated with menopauseJoAnn V Pinkerton, James Simon, Nick Panay, et al.
Pageof 9